Gary Holland to CD4 Lymphocyte Count
This is a "connection" page, showing publications Gary Holland has written about CD4 Lymphocyte Count.
Connection Strength
0.721
-
Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol. 2008 Jan; 145(1):12-22.
Score: 0.068
-
Decreased macular leukocyte velocity in human immunodeficiency virus-infected individuals. Am J Ophthalmol. 2001 Nov; 132(5):711-9.
Score: 0.045
-
Ischemic maculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 2001 Nov; 132(5):727-33.
Score: 0.045
-
Immune recovery uveitis. Am J Ophthalmol. 2000 Jul; 130(1):103-6.
Score: 0.041
-
Contralateral Eye Involvement and Retinal Detachment in Patients with Cytomegalovirus Retinitis Treated with Intravitreous Ganciclovir. Ocul Immunol Inflamm. 2021 Aug 18; 29(6):1145-1150.
Score: 0.040
-
Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1999 Jan; 106(1):133-41.
Score: 0.037
-
Active cytomegalovirus retinitis after the start of antiretroviral therapy. Br J Ophthalmol. 2019 02; 103(2):157-160.
Score: 0.036
-
Uveitis associated with human immunodeficiency virus infection. Am J Ophthalmol. 1998 Mar; 125(3):301-5.
Score: 0.035
-
Chronic multifocal retinal infiltrates in patients infected with human immunodeficiency virus. Am J Ophthalmol. 1998 Mar; 125(3):312-24.
Score: 0.035
-
Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy. Am J Ophthalmol. 2017 Feb; 174:23-32.
Score: 0.032
-
Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare. Br J Ophthalmol. 2016 08; 100(8):1017-21.
Score: 0.031
-
Incidence and long-term outcomes of the human immunodeficiency virus neuroretinal disorder in patients with AIDS. Ophthalmology. 2015 Apr; 122(4):760-8.
Score: 0.028
-
Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mL. Clin Exp Ophthalmol. 2014 Mar; 42(2):118-25.
Score: 0.025
-
Didanosine-associated retinal toxicity in adults infected with human immunodeficiency virus. JAMA Ophthalmol. 2013 Feb; 131(2):255-9.
Score: 0.024
-
Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection. Am J Ophthalmol. 2012 Apr; 153(4):734-42, 742.e1.
Score: 0.023
-
Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with visual function. Am J Ophthalmol. 2012 Mar; 153(3):428-433.e1.
Score: 0.022
-
Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol. 2012 Mar; 153(3):434-444.e1.
Score: 0.022
-
Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group. Am J Ophthalmol. 2008 Mar; 145(3):453-462.
Score: 0.017
-
Hemorheologic abnormalities associated with HIV infection: altered erythrocyte aggregation and deformability. Invest Ophthalmol Vis Sci. 2006 Sep; 47(9):3927-32.
Score: 0.016
-
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):684-94.
Score: 0.015
-
The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. HIV Clin Trials. 2005 May-Jun; 6(3):136-46.
Score: 0.014
-
Posterior intracorneal opacities in patients with HIV infection. Ocul Immunol Inflamm. 2005 Feb; 13(1):25-31.
Score: 0.014
-
An assessment of polymorphonuclear leukocyte rigidity in HIV-infected individuals after immune recovery. Invest Ophthalmol Vis Sci. 2002 Jun; 43(6):1857-61.
Score: 0.012
-
Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis. 2001 May 01; 183(9):1399-404.
Score: 0.011
-
Increased polymorphonuclear leucocyte rigidity in HIV infected individuals. Br J Ophthalmol. 2000 Jul; 84(7):727-31.
Score: 0.010
-
Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1998 Aug; 116(8):1011-7.
Score: 0.009
-
Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 1998 Mar; 125(3):292-300.
Score: 0.009
-
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis. 1998 Jan; 177(1):48-56.
Score: 0.009